CD19 CAR-T

CD19-targeted chimeric antigen receptor T-cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 CAR-T, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL [Phase 2]